Free Trial

Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down - What's Next?

Bio-Rad Laboratories logo with Medical background

Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO.B - Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $343.85, but opened at $319.37. Bio-Rad Laboratories shares last traded at $319.37, with a volume of 256 shares trading hands.

Bio-Rad Laboratories Stock Performance

The company's 50 day moving average price is $337.61 and its two-hundred day moving average price is $333.15. The firm has a market cap of $8.74 billion, a PE ratio of -11.42 and a beta of 0.73. The company has a quick ratio of 4.52, a current ratio of 6.14 and a debt-to-equity ratio of 0.16.

Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $2.90 earnings per share for the quarter. Bio-Rad Laboratories had a negative net margin of 30.18% and a positive return on equity of 3.74%.

Bio-Rad Laboratories Company Profile

(Get Free Report)

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.

See Also

Should You Invest $1,000 in Bio-Rad Laboratories Right Now?

Before you consider Bio-Rad Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bio-Rad Laboratories wasn't on the list.

While Bio-Rad Laboratories currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines